Lower-Protein Toddler Formula Does Not Reduce BMI at Age 2, Trial Finds

Why It Matters

The findings temper expectations that reducing formula protein alone can curb early obesity, but they highlight protein’s role in shaping growth velocity, informing pediatric nutrition guidelines and formula formulation strategies.

Key Takeaways

• Lower‑protein formula did not change BMI z‑score at 24 months.
• High‑protein group showed higher weight and length z‑scores versus WHO.
• Transient BMI reduction appeared at 18 months in low‑protein cohort.
• Protein contributed 14% vs 18% of energy in low vs high groups.
• Authors suggest limiting toddler milk to 200‑400 ml daily.

Pulse Analysis

The early protein hypothesis, first articulated after the CHOP trial, linked high protein intake in infancy to later obesity via elevated branched‑chain amino acids and mTOR activation. While infant formula reformulation has shown promise, the toddler period—when solid foods diversify and milk still supplies roughly half of protein—remains less studied. Understanding whether protein modulation can still influence adiposity is crucial for pediatric nutrition policy and for manufacturers seeking evidence‑based product differentiation.

The ToMI trial addressed this gap by randomizing over 1,600 healthy toddlers in Spain and Germany to either a low‑protein formula mimicking human‑milk protein density or a conventional high‑protein cow‑milk formula. Over two years, the low‑protein group consumed 14% of energy from protein versus 18% in the high‑protein arm. Although BMI z‑scores converged by 24 months, the high‑protein cohort consistently outpaced WHO growth references in weight and length, suggesting protein drives overall growth velocity more than fat accumulation during the second year of life.

For clinicians, the practical takeaway is to monitor total protein exposure rather than focusing solely on BMI outcomes. Limiting toddler milk to 200‑400 ml per day can keep protein intake within recommended ranges and may promote steadier growth patterns. Formula makers may need to reformulate young‑child products to align with these emerging data, while long‑term follow‑up will determine whether early growth differences translate into reduced obesity risk later in childhood. The study underscores the nuanced role of dietary protein in early development and sets a benchmark for future research on metabolic programming beyond infancy.